Page last updated: 2024-08-24

pivalyloxymethyl butyrate and Leukemia, Myeloid, Acute, M4

pivalyloxymethyl butyrate has been researched along with Leukemia, Myeloid, Acute, M4 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aviram, A; Ben-Dror, I; Maron, L; Nudelman, A; Rabizadeh, E; Rephaeli, A; Shaklai, M1

Other Studies

1 other study(ies) available for pivalyloxymethyl butyrate and Leukemia, Myeloid, Acute, M4

ArticleYear
Effect of the cytostatic butyric acid pro-drug, pivaloyloxymethyl butyrate, on the tumorigenicity of cancer cells.
    Journal of cancer research and clinical oncology, 1997, Volume: 123, Issue:5

    Topics: Animals; Antineoplastic Agents; Butyrates; Carcinoma, Lewis Lung; Gene Expression Regulation, Neoplastic; Genes, jun; Genes, myc; Leukemia, Myelomonocytic, Acute; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; RNA, Neoplasm; Tumor Cells, Cultured

1997